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BACKGROUND 
Over the past two decades, the United States has experienced a 
dramatic increase in the number of drug-related overdose deaths, 
driven in large part by the opioid epidemic. In 2017 alone, more than 
70,000 people died from a drug overdose, and 67.8% of these deaths 
were opioid-related.¹ Over the course of the epidemic, changes in 
prescribing patterns have reduced access to prescription opioids, 
but overdose deaths involving heroin and synthetic opioids such as 
illicitly manufactured fentanyl have increased.² Most recently, deaths 
involving synthetic opioids have spiked, increasing 71% per year from 
2013 to 2017.³
Although urban areas have higher rates of overall illicit drug use,⁴ 
rates of opioid misuse are more comparable across the rural-urban 
spectrum.⁵  In 2018, rates of opioid misuse were 3.5% in large 
metropolitan statistical areas (MSAs), 4.1% in small MSAs, and 3.8% 
in non-MSAs.¹ Despite the similar prevalence of opioid misuse across 
MSAs, there is evidence to suggest that use of opioids may be more 
lethal for those living in rural areas. A recent analysis examining 
county-level factors associated with opioid-related deaths found 
rurality to be a significant determinant of opioid-related mortality.⁶ 
Observing drug overdose trends from 1999 to 2015, Mack and 
colleagues found that while overdose death rates were initially higher 
in metropolitan areas, this difference disappeared in 2004, and by 2015 
rates were higher in nonmetropolitan areas.⁴ 
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Key Findings
• Opioid-related visits (ORVs) 
to rural and urban emergency 
departments (EDs), as a 
proportion of total visits, 
increased between 2006 and 
2013. 
• Rural ORV rates were lower 
than urban rates in both 
periods, but the difference 
narrowed because of 
somewhat higher rural 
increases.
• Rural ORVs were more 
likely than those in urban 
areas to be by patients 
aged 65 and older and to 
involve concurrent use of 
benzodiazepines. 
• One fifth of ORVs by rural 
residents occurred in urban 
EDs and rural EDs were more 
likely to transfer patients to 
another hospital.
• More research is needed to 
understand the impact of rural 
residents’ treatment in other 
facilities on short- and long-
term outcomes for patients 
who experience an ORV.
For more information about this study, 
contact Erika Ziller, PhD
erika.ziller@maine.edu
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One impact of the higher rates of opioid misuse and related overdoses 
has been an increased strain on emergency departments (EDs). In 
2016, the rate of opioid poisoning-related ED visits was 62 per 100,000 
population.¹ An analysis of ED data from 52 jurisdictions in 45 states 
found that rates of ED visits for suspected opioid-involved overdoses 
varied widely by state and region, but overall trends showed an 
increase of 5.6% each quarter from 2016-2017.⁷ These trends reflect the 
wider impact of the opioid crisis on hospital services. From 1993 to 
2016, hospital discharges for opioid use disorder (OUD) quadrupled, 
from 38.3 to 154.5 per 100,000.⁸ 
Although analyses of opioid overdoses by rural-urban status have 
found that rates are generally higher in urban than rural EDs, 
rates have increased for all regions.1, 7, 9, 10 These studies, however, 
have been limited in geographic or temporal scale, resulting in an 
incomplete understanding of national ED visits for opioid poisoning 
by metropolitan status over time. Even if rates are lower in rural areas, 
increasing overdose rates may prove especially challenging for rural 
EDs already experiencing growing demand for their services. From 
2005 to 2016, overall ED visit rates at rural hospitals rose more than 
Maine Rural Health Research Center   •   February 2021
50%, from 36.5 to 64.5 visits per 100,000 people, 
while urban EDs only saw a slight increase over the 
same time period.11 
It is especially important to assess opioid poisoning 
visit rate increases in rural EDs, given the resource 
constraints that they face. Relative to urban facilities, 
rural EDs typically have lower staffing levels,12 
fewer emergency medicine physicians and on-
call specialists,12 fewer training opportunities,12 
and more limited access to advanced medical 
technologies.13 Thus, when faced with climbing 
rates, rural EDs may have difficulties addressing 
the acute needs of opioid overdose patients while 
serving other members of their patient populations 
at the same time; as a result, they may need to 
create new protocols to cope with disruptions in 
workflow. Although physical management of acute 
opiate overdose may be relatively straightforward 
(airway maintenance, reversal agents, withdrawal 
support),14 there is growing recognition that an 
opioid overdose may present a unique opportunity 
for future overdose preventions including naloxone 
prescribing or initiation of treatment.15 Yet, because 
rural hospitals may have more limited clinical 
capabilities than urban hospitals,16 and because 
rural communities typically have fewer providers 
of substance use disorder (SUD) treatment,17, 18 rural 
EDs may confront special obstacles in arranging 
appropriate, psychosocial and post-emergency care 
for patients who present with opioid poisoning. 
EDs are a critical rural health resource and may play 
an important frontline role in addressing the opioid 
epidemic. However, we lack information on whether 
opioid poisonings place a disproportionate burden 
on rural EDs or whether rural EDs have the capacity 
to address patients experiencing an overdose. The 
purpose of this study was to gain insight about 
rural ED visits for acute opioid poisoning and how 
they compare with urban ED visits. We explored 
how rural and urban rates of opioid-related visits 
changed between 2006 and 2013, and how they 
compared to each other in each year. We also 
analyzed what proportion of rural residents sought 
care for opioid poisoning at urban EDs, particularly 
compared to other diagnoses and between the two 
time periods. Finally, we examined whether these 
opioid-related visits to rural EDs had different 
outcomes such as transfer or death than urban visits.
METHODS
This study used the 2006 and 2013 Nationwide 
Emergency Department Sample (NEDS), a data 
set created as part of the Agency for Healthcare 
Research and Quality’s Healthcare Cost and 
Utilization Project. At the time we initiated this 
study, the 2013 dataset was the most recent year 
available. We examined rural and urban opioid-
related visits to ED, including rate change over time, 
and the outcomes of these ED visits (treatment and 
release, inpatient admission, transfer, and death). 
By opioid-related visits (ORVs), we specifically 
mean visits to a rural or urban ED with a diagnosis 
of acute poisoning by a prescription or illicit 
opioid. The study addressed the following research 
questions:
1. Did opioid-related ED use differ across rural
and urban EDs in 2013? How did rural opioid-
related visit rates change from 2006 to 2013 (in
absolute rates and relative to urban)?
2. In each year, what proportion of rural patients
received opioid-related care in rural versus
urban EDs?
3. Did rates of various outcomes (e.g.,
admissions, transfers, and death) differ across
rural and urban EDs in 2013? How did rates
of rural outcome change from 2006 to 2013,
including relative to urban?
Data: The NEDS contains data from a sample of 
ED visits in the U.S. that are weighted to enable 
nationally representative estimates about EDs 
and ED visits. The EDs that contribute data to the 
NEDS approximate a 20%, stratified sample of all 
U.S. hospital-based EDs. It contains information on 
injury-related ED visits including: type and severity 
of injury; whether the injury resulted in death; post-
ED disposition (e.g., whether the patient was treated 
and released, admitted, or transferred to another 
facility); and patient characteristics. 
Dependent Variables: To measure opioid-related 
ED use, we used ICD-9-CM diagnosis and injury 
codes to identify opioid-related ED visits each 
year. (Examples of relevant codes include: 965.01 
for poisoning by heroin; 965.09 for poisoning by 
other opiates and related narcotics; E850.1 for 
accidental poisoning by methadone; and 305.52 
for nondependent opioid abuse, episodic use). All 
ED visits were categorized as opioid-related or 
not opioid-related. To assess outcomes following 
opioid-related visits, we classified each as resulting 
in release from the ED, inpatient admission, transfer 
to a non-hospital health care provider, or death. 
Independent Variables: The two independent 
variables in the study were ED location (urban 
or rural) and time period (2006 versus 2013). To 
indicate the rurality of the county in which an ED 
is located, the NEDS uses an aggregated version of 
the Urban Influence Codes (UICs) devised by the 
United States Department of Agriculture’s Economic 
2
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Research Service. While the NEDS divides counties 
into metropolitan, micropolitan, and non-core, we 
combined micropolitan and non-core into a single 
rural variable to increase our rural sample size.
Covariates: Our covariates included patient 
characteristics: age, gender, median household 
income in the patient’s ZIP code, type of opiate 
ingested, and presence of co-morbidities. We also 
included census region where the hospital is located 
as a covariate (Northeast, South, Midwest and West). 
Analysis: In bivariate analyses, we used chi-
square tests to compare opioid-related ED use and 
outcomes of ORVs by rurality of ED location and 
across time periods. We also used chi-square to 
test rural-urban differences in patient residence by 
ED location within each time period. To further 
understand rural-urban differences in transfer rates 
for ORVs, we used logistic regression to examine the 
odds that a rural hospital would transfer a patient to 
another facility, controlling for the covariates listed 
above. We used SUDAAN (Release 11.0.1, Research 
Triangle Park, NC: 2012) for all analyses to account 
for stratification and weighting in the NEDS data. 
Unless otherwise noted, all differences discussed in 
this brief were statistically significant with p-values 
at or below 0.05.
FINDINGS
Prevalence of Opioid-Related Visits
Table 1. Opioid-Related Emergency Department (ED) Visits, by Year and Rural or Urban Hospital Location
SOURCE:  Nationwide Emergency Department Sample, 2006 and 2013
Chi square test of difference by ED location (rural vs. urban) in 2006 significant at: ¹p < 0.05, ²p < 0.01, ³p < 0.001, ⁴p < 0.0001.
Chi square test of difference by ED location (rural vs. urban) in 2013 significant at:  ip < 0.05, iip < 0.01, iiip < 0.001, ivp < 0.0001.
Chi square test of difference by year (2006 vs. 2013) among rural EDs significant at: ap < 0.05, bp < 0.01, cp < 0.001, dp < 0.0001.
Chi square test of difference by year  (2006 vs. 2013) among rural EDs significant at: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
The proportion of visits that were related to the use 
of any opioid was higher in urban than rural EDs 
in both 2006 and 2013. These differences decreased 
slightly between the two time periods, largely 
because rural ORV rates grew faster than urban 
rates (Table 1). In 2006, 64 out of every 100,000 
visits to a rural ED was related to opioid poisoning, 
compared to 92 per 100,000 in urban. By 2013, 
rural ORV rates had increased 39 percent, to 89 per 
100,000 visits. Urban rates grew to 124 per 100,000 
visits, an increase of about 35 percent.
Most of the rural-urban difference in ORV rates 
appears to be driven by higher urban versus rural 
rates of poisoning by heroin or an unspecified 
opioid. Rural-urban differences in methadone-
related visits were minimal in each year use 
(10 versus 8 per 100,000 in 2006 and 7 versus 6 
per 100,000 in 2013). There was no statistically 
significant rural-urban difference in either year 
for ED visits that were related to non-methadone 
prescription drugs, although both rural and urban 
EDs saw an increase in the rate of visits related to 
prescription opioids other than methadone. Urban 
EDs were somewhat more likely than rural to see 
2006 2013
Urban ED Rural ED Urban ED Rural ED
Weighted N = 
97,267,531 visits
Weighted N = 
22,766,219 visits
Weighted N =  
110,136,173 visits
Weighted N =  
24,011,421 visits
Opioid-related visits per 100,000 visits
Any opioid4,iv, d, **** 92 64 124 89
Heroin4,iv, b,**** 26 3 42 11
Methadone1, i, d, ** 10 8 7 6
Non-methadone 
prescription opi-
oidns, ns, a, *
38 38 41 44
Unspecified 
opioid1,ii,d, **** 17 14 31 26
Multiple opioidsns, 
ns, d, **** 2 1 3 3
cases of unspecified opioid poison (17 versus 14 per 
100,000 in 2006 rising to 31 versus 26 per 100,000 in 
2013). During 2013, the rate of heroin-related urban 
ED visits was 42 per 100,000 total visits versus 11 
in rural EDs. However, it is important to note that 
between 2006 and 2013, the rate of heroin-related 
visits to rural EDs nearly quadrupled, rising from 3 
per 100,000 to 11 per 100,000.
Given the substantially lower proportion of ED 
visits related to opioids in rural EDs, we next sought 
to understand whether some segment of rural 
residents who experience an ORV actually end up 
at urban EDs. As demonstrated in Figure 1, in 2006, 
about one out of six ORVs by a rural resident took 
place in an urban ED (16 percent). This compared 
to only 13 percent of ED visits for all other types 
of diagnoses combined (p. <.05). This proportion 
rose to 20 percent of ORVs in 2013, meaning that 
one out of every five ED visits for opioid poisoning 
experienced by a rural resident in that year occurred 
within an urban ED. However, only 15 percent of 
rural residents who received ED treatment for a 
non-opioid-related diagnosis did so in an urban ED. 
Among urban residents, about 1 percent of all ORVs 
were to a rural ED in both 2006 and 2013 (data not 
shown).
Patient Characteristics and Comorbidities 
among Opioid-Related Visits
The characteristics of patients who presented for 
an ORV to rural EDs differed somewhat from 
those going to urban EDs in both 2006 and 2013 
(Table 2). For example, visits by children (under 
age 18), older adults (age 65+), and female patients 
comprised a higher proportion of ORVs to rural EDs 
compared with urban EDs. Not surprisingly given 
the economic characteristics of rural places, rural 
ORVs were more likely than urban ORVs to be made 
by individuals from lower income communities 
(defined by median incomes below the U.S. 
median). Potentially reflecting these income and 
age differences, ORVs to rural EDs were more likely 
to be paid for by Medicare or Medicaid than were 
ORVs to urban EDs in 2006. By 2013, the percentage 
of rural ORVs covered by Medicaid had declined 
while Medicare as a payer increased. In 2013, 
nearly one-third (32 percent) of all rural ORVs were 
covered by Medicare, compared with 27 percent of 
urban ORVs.
To assess whether there were differences in the 
underlying or acute patient health status of rural 
versus urban ED visits for opioid poisoning, we 
analyzed comorbid condition diagnoses appearing 
in each ORV record. Between 2006 and 2013, the 
proportion of ORVs accompanied by a chronic 
pulmonary condition increased, particularly in 
rural EDs. Similarly, rates of concurrent respiratory 
failure among ORVs increased between 2006 and 
2013, nearly doubling for rural ORVs. About 30 
percent of rural and urban ORVs were associated 
with comorbid mood or psychotic disorders in both 
years. Compared with urban ORVs, a somewhat 
higher proportion of rural ORVs included a 
concurrent diagnosis of benzodiazepine intoxication 
(13 versus 10 percent in 2013). 
Opioid-Related Visit Outcomes
Among individuals presenting at rural and urban 
EDs for ORVs, close to half are treated and released, 
while more than 40 percent end up admitted to 
that hospital (Table 3). There was no statistically 
significant difference in these outcomes for rural 
versus urban hospitals in either year, or change 
among urban hospitals across years. However, 
in both years the rate of ORVs that resulted in a 
transfer to another hospital was four to five times 
higher for rural EDs compared with urban EDs (8 
percent versus two percent in 2013). A very small 
number of ORVs (less than 1 percent) resulted in 
death in the ED across geographic locations and 
study years and the rural rates did not differ from 
urban in either year. 
To understand whether the rural-urban differences 
in hospital transfers for an ORV may be explained 
by differences in the patient characteristics of 
visits, we conducted a pair of adjusted and 
unadjusted logistic regressions for 2013. The 
first model estimated the simple odds that a 
rural versus urban ORV would end in a hospital 
transfer versus admission to the same hospital 
as the ED. The second model estimated the rural 
odds of a hospital transfer, controlling for patient 
age, sex, comorbidities, median income in their 
neighborhood, and the hospital’s region of the 
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Figure 1. Percentage of Rural Residents’ ED Visits 
Made to an Urban ED for Opioid Poisoning Versus All 
Other Diagnoses






Opioid-Related Visit Not Opioid Related
Table 2.  Patient Characteristics and Comorbidities among Opioid-Related
Emergency Department (ED) Visits, by Year and Rural or Urban Hospital Location
SOURCE:  Nationwide Emergency Department Sample, 2006 and 2013
Chi square test of difference by ED location (rural vs. urban) in 2006 significant at: ¹p < 0.05, ²p < 0.01, ³p < 0.001, ⁴p < 0.0001.
Chi square test of difference by ED location (rural vs. urban) in 2013 significant at: ip < 0.05, iip < 0.01, iiip < 0.001, ivp < 0.0001.
Chi square test of difference by year (2006 vs. 2013) among rural EDs significant at: ap < 0.05, bp < 0.01, cp < 0.001, dp < 0.0001.
Chi square test of difference by year (2006 vs. 2013) among rural EDs significant at: *p < 0.05, ** p < 0.01, ***p < 0.001, ****p < 0.0001.
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2006 2013
Urban ED Rural ED Urban ED Rural ED
(N = 89,612 
ORVs)
(N = 14,622 
ORVs)
(N = 137,312 
ORVs)
(N = 22,341 
ORVs)
Percent of Visits by Patient Characteristic
Characteristic
Age4, d,****
0-17 4.3 7.1 3.3 4.6
18-34 35.9 28.9 39.6 29.8
35-64 52.7 52.8 47.7 51.6
65+ 7.1 11.2 9.5 13.9
Female4,iv, n.s., n.s. 45.4 53.7 45.8 54.6
Median Household Income in Patient’s 
ZIP Code below US Median4,iv, n.s, n.s.
52.3 84.0 54.1 83.8
Primary Payment Source 4, iv,d,*
Medicaid 22.1 27.1 24.7 25.2
Medicare 19.0 26.5 23.1 31.7
Private 22.8 21.3 20.8 18.7
Self-pay 28.7 21.5 25.0 20.1
No charge 3.2 0.3 1.9 0.5
Other 4.2 3.7 4.6 3.8
Comorbid Diagnosis at Admission
Chronic pulmonary conditionns,i,d,**** 11.2 11.2 14.4 16.3
Mood or psychotic disorderns,ns,ns,** 29.1 28.6 32.0 31.6
Alcohol-related disordersns, ii, a,ns 11.9 11.0 13.2 11.2
Cancersns,ns,ns,* 3.2 3.1 3.6 4.2
Neurological disordersns,ns, b, ns 6.1 6.0 7.2 6.9
Alcohol intoxicationns, ns, b, * 4.3 4.6 3.5 3.1
Benzodiazepine intoxication1,iv,ns, ns 9.9 11.9 9.7 12.9
Respiratory failure4,ns,d, iv 10.3 6.4 13.4 12.0
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rural residents who experience opioid poisoning 
may be voluntarily, or involuntarily, not seeking 
care in their local hospitals. Our analysis confirmed 
that 20 percent of rural residents who experienced 
an ORV did so at an urban ED in 2013, compared 
with only 15 percent of all other ED visit types. It is 
unclear whether this difference is driven by friends 
and family bringing rural individuals to urban EDs, 
perhaps in response to stigma or other concerns, or 
whether first responders are making these decisions. 
Prior research indicates that the emergency medical 
services (EMS) protocols may divert severe trauma 
or other emergencies directly to urban EDs, 
particularly if the rural hospital has limited trauma 
or intensive care services.19 It is possible that rural 
hospitals may doubt their capacity to handle opioid 
overdoses and may be peremptorily routing patients 
to larger, more urban facilities. 
This potential concern about rural hospital capacity 
appears to be supported by rural hospitals’ 
decisions to transfer ORV admissions to other 
hospitals at substantially higher rates than urban 
hospitals. When controlling for the characteristics 
and health status of patients, the odds of a transfer 
were five times that for rural versus urban hospitals. 
Unfortunately, the NEDs does not provide detail 
about the hospitals to which individuals are 
transferred, which is a limitation of our study. The 
NEDs also does not allow us to distinguish between 
types of rural hospitals and Critical Access Hospitals 
may face unique pressures to transfer based on 
Medicare policy that limits CAH stays to 96 hours.  
country. In other words, even if rural and urban 
patients shared the same characteristics, what would 
be the ratio of rural transfers to urban transfers? 
Compared to urban EDs, patients arriving at rural 
EDs for an ORV had 4.8 times higher unadjusted 
odds of being transferred to a different hospital. 
When we controlled for the patient characteristics 
described above, the odds of a rural ORV visit 
ending in a transfer increased slightly to 5.3 times 
that of urban. This suggests that when key risk 
factors for poor ORV outcomes are held constant, 
rural EDs are even more likely than urban EDs to 
transfer a patient.
DISCUSSION AND POLICY IMPLICATIONS
Our findings indicate that ORVs made up an 
increasing proportion of all rural and urban ED 
visits in 2013 compared with 2006 and the rate of 
increase was higher in rural. This reflects other 
data showing historically lower rural rates of death 
from overdose by drugs of all kinds, yet a more 
rapid increase among rural populations has led 
to overdose death rates that were slightly higher 
in rural areas in 2015 (17 versus 16 per 100,000).4 
Although the rural-urban difference in ORVs 
narrowed by 2013, the rate of ORVs among all ED 
visits was lower in rural compared with urban 
hospitals in both years.
Given that rural-urban rates of opioid use are 
roughly comparable,⁵ the relatively lower volume 
of ORVs in rural EDs suggests that a segment of 
SOURCE:  Nationwide Emergency Department Sample, 2006 and 2013
Chi square test of difference by ED location (rural vs. urban) in 2006 significant at: ¹p < 0.05, ²p < 0.01, ³p < 0.001, ⁴p < 0.0001.
Chi square test of difference by ED location (rural vs. urban) in 2013 significant at: ip < 0.05, iip < 0.01, iiip < 0.001, ivp < 0.0001.
Chi square test of difference by year (2006 vs. 2013) among rural EDs significant at: ap < 0.05, bp < 0.01, cp < 0.001, dp < 0.0001.
Chi square test of difference by year (2006 vs. 2013) among rural EDs significant at: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Table 3. Outcomes of Opioid-Related Emergency Department (ED) Visits,
by Year and Rural or Urban Hospital Location
2006 2013
Urban ED Rural ED Urban ED Rural ED
(Weighted 
N = 89,612 
ORVs)
(Weighted 
N = 14,622 
ORVs)
(Weighted 
N = 137,321 
ORVs)
(Weighted 
N = 21,341 
ORVs)
Column % Column % Column % Column %
Outcome of ED Visit
Treated and releasedns, i, ns,ns 48.9 44.1 52.0 48.1
Admitted to same hospitalns,ns,ns,ns 46.1 47.3 45.7 43.2
Transferred to another hospital4,iv, a,ns 1.3 6.6 1.8 8.1
Died in EDns,ns,a,ns 0.1 0.3 0.2 0.2
Not admitted, destination unknownns, ns, d,ns 3.6 1.8 0.3 0.4
2006 2013
Urban ED Rural ED Urban ED Rural ED
(Weighted 
N = 89,612 
ORVs)
(Weighted 
N = 14,622 
ORVs)
(Weighted 
N = 137,321 
ORVs)
(Weighted 
N = 21,341 
ORVs)
Column % Column % Column % Column %
Outcome of ED Visit
Treated and releasedns, i, ns,ns 48.9 44.1 52.0 48.1
Admitted to same hospitalns,ns,ns,ns 46.1 47.3 45.7 43.2
Transferred to another hospital4,iv, a,ns 1.3 6.6 1.8 8.1
Died in EDns,ns,a,ns 0.1 0.3 0.2 0.2
Not admitted, destination unknownns, ns, d,ns 3.6 1.8 0.3 0.4
In addition to concerns about rural hospital capacity, 
our analysis of patient characteristics found some 
important differences between the patients who 
appear for ORVs in rural versus urban EDs. In 
particular, a greater proportion of ORVs in rural EDs 
were patients aged 65 and older. This may be driven 
by rural-urban differences in prescribing patterns 
for opioid medications. For example, prior research 
indicates that in 2015-16, rural older adults (65+) 
were more frequently prescribed opioids than were 
their urban counterparts.20 It is unclear from our 
study whether these older adults in rural EDs were 
experiencing OUDs, or whether they were taking 
opioids generally as prescribed but experienced an 
overdose because of lower health literacy or other 
confusion about appropriate dosing. This suggests 
that we need more research into the opioid use 
patterns of older adults, particularly for those living 
in rural areas, to better understand the education 
needs of rural providers and patients and the SUD 
treatment needs of rural older adults. 
More research is needed to determine whether the 
potential diversion to urban EDs and the transfer of 
patients to other facilities has a positive or negative 
impact on patients’ short- and long-term outcomes. 
For example, many EDs have begun offering 
medication-assisted treatment (MAT) for opioid use 
disorders to individuals experiencing an overdose 
while they are in the ED, as evidence suggests 
this may be an optimal time to engage individuals 
in treatment.21 Whether and how rural residents’ 
treatment in urban EDs or transfer to other facilities 
affects the initiation and maintenance of treatment 
will be an important question to address for the 
future.
Finally, given the age of the data used for these 
analyses, it will be important to update this study 
in the near future. More recent data from the NEDS 
show a generally increasing trend in opioid-related 
ED visits from 2013-2017;22 increasing prevalence of 
overdoses involving synthetic opioids during this 
time period³ may also have important consequences 
for EDs in both rural and urban places.
Maine Rural Health Research Center   •   February 2021   7
This study was supported by the Federal Office of Rural Health Policy (FORHP), Health Resources and 
Services Administration (HRSA), U.S. Department of Health and Human Services (HHS) under cooperative 
agreement #U1CRH03716. The information, conclusions and opinions expressed in this brief are those of the 
authors and no endorsement by FORHP, HRSA, or  HHS is intended or should be inferred.
Data Acknowledgement:
This study was conducted using data from the Nationwide 
Emergency Department Sample (NEDS), Healthcare 
Cost and Utilization Project (HCUP), Agency for 
Healthcare Research and Quality. The following states and 
organizations are HCUP partners:
Alaska Department of Health and Social Services
Alaska State Hospital and Nursing Home Association
Arizona Department of Health Services
Arkansas Department of Health
California Office of Statewide Health Planning and Development
Colorado Hospital Association
Connecticut Hospital Association
Delaware Division of Public Health
District of Columbia Hospital Association
Florida Agency for Health Care Administration
Georgia Hospital Association
Hawaii Laulima Data Alliance
Hawaii University of Hawaii at Hilo




Kentucky Cabinet for Health and Family Services
Louisiana Department of Health
Maine Health Data Organization
Maryland Health Services Cost Review Commission
Massachusetts Center for Health Information and Analysis
Michigan Health & Hospital Association
Minnesota Hospital Association (provides data for Minnesota 
and North Dakota)
Mississippi State Department of Health
Missouri Hospital Industry Data Institute
Montana Hospital Association
Nebraska Hospital Association
Nevada Department of Health and Human Services
New Hampshire Department of Health & Human Services
New Jersey Department of Health
New Mexico Department of Health
New York State Department of Health
North Carolina Department of Health and Human Services
North Dakota (data provided by the Minnesota Hospital 
Association)
Ohio Hospital Association
Oklahoma State Department of Health
Oregon Association of Hospitals and Health Systems
Oregon Office of Health Analytics
Pennsylvania Health Care Cost Containment Council
Rhode Island Department of Health
South Carolina Revenue and Fiscal Affairs Office
South Dakota Association of Healthcare Organizations
Tennessee Hospital Association
Texas Department of State Health Services
Utah Department of Health
Vermont Association of Hospitals and Health Systems
Virginia Health Information
Washington State Department of Health
West Virginia Department of Health and Human Resources, 
West Virginia Health Care Authority




Maine Rural Health Research Center 
https://mrhrc.org/
Muskie School of Public Service, 34 Bedford Street 
PO Box 9300, Portland, Maine 04104
13. Hines A, Fraze T, Stocks C. Emergency Department Visits 
in Rural and Non-Rural Community Hospitals, 2008. 
Agency for Healthcare Research and Quality; 2011. HCUP 
Statistical Brief #116. http://www.hcup-us.ahrq.gov/
reports/statbriefs/sb116.pdf
14. Parthvi R, Agrawal A, Khanijo S, Tsegaye A, Talwar A. 
Acute Opiate Overdose: An Update on Management 
Strategies in Emergency Department and Critical Care 
Unit. Am J Ther. 2019;26(3):e380-e387. doi:10.1097/
mjt.0000000000000681
15. Duber HC, Barata IA, Cioè-Peña E, et al. Identification, 
Management, and Transition of Care for Patients With 
Opioid Use Disorder in the Emergency Department. 
Ann Emerg Med. 2018;72(4):420-431. doi:10.1016/j.
annemergmed.2018.04.007
16. Joynt KE, Harris Y, Orav EJ, Jha AK. Quality of Care and 
Patient Outcomes in Critical Access Rural Hospitals. J Am 
Med Assoc. 2011;306(1):45-52. doi:10.1001/jama.2011.902
17. Borders TF, Booth BM. Research on Rural Residence and 
Access to Drug Abuse Services: Where Are We and Where Do We 
Go? J Rural Health. 2007;23(Supplemental Issue):79-83. 
18. Cummings JR, Wen H, Ko M, Druss BG. Race/Ethnicity 
and Geographic Access to Medicaid Subtance Use Disorder 
Treatment Facilities in the United States. JAMA Psychiatry. 
2014;71(2):190-196. doi:10.1001/jamapsychiatry.2013.3575
19. iVantage Health Analytics. 2013 National Rural Emergency 
Department Study: Establishing Rural Relevant 
Benchmarks. iVantage; 2013.  https://www.ivantagehealth.
com/wp-content/uploads/2013/09/6th-Annual-ED-Study-
vF2.pdf
20. Moriya AS, Miller GE. Any Use and Frequent Use of Opioids 
among Elderly Adults in 2015-2016, by Socioeconomic 
Characteristics. Agency for Healthcare Research and 
Quality;2018. Statistical Brief #515. https://meps.ahrq.gov/
data_files/publications/st515/stat515.shtml
21. D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency 
department-initiated buprenorphine/naloxone treatment 
for opioid dependence: a randomized clinical trial. JAMA. 
Apr 28 2015;313(16):1636-44. doi:10.1001/jama.2015.3474
22. Agency for Healthcare Research and Quality. Healthcare 
Cost and Utilization Project, Nationwide Emergency Department 
Sample, 2010-2017. Accessed October 20, 2020. https://www.
hcup-us.ahrq.gov/faststats/OpioidUseServlet?setting1=ED
REFERENCES
1. Centers for Disease Control and Prevention. 2019 Annual 
Surveillance Report of Drug-Related Risks and Outcomes — 
United States Surveillance Special Report. CDC; 2019.  https://
www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-
surveillance-report.pdf
2. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. 
A recent history of opioid use in the US: Three decades of 
change. Subst Use Misuse. 2019;54(2):331-339. doi:10.1080/10
826084.2018.1517175
3. Hedegaard H, Minino AM, Warner M. Drug Overdose Deaths 
in the United States, 1999-2017. National Center for Health 
Statistics; 2018. NCHS Data Brief No. 329. https://www.cdc.
gov/nchs/data/databriefs/db329-h.pdf
4. Mack KA, Jones CM, Ballesteros MF. Illicit Drug Use, 
Illicit Drug Use Disorders, and Drug Overdose Deaths 
in Metropolitan and Nonmetropolitan Areas - United 
States. MMWR Surveill Summ. Oct 20 2017;66(19):1-12. 
doi:10.15585/mmwr.ss6619a1
5. Lenardson JD, Gale J, Ziller EC. Rural Opioid Abuse: 
Prevalence and User Characteristics. 2016. PB-63-1. https://
digitalcommons.usm.maine.edu/behavioral_health/22/
6. Langabeer JR, Chambers KA, Cardenas-Turanzas M, 
Champagne-Langabeer T. County-level factors underlying 
opioid mortality in the United States. Subst Abus. Mar 18 
2020:1-7. doi:10.1080/08897077.2020.1740379
7. Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital Signs: 
Trends in Emergency Department Visits for Suspected 
Opioid Overdoses - United States, July 2016-September 
2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279-285. 
doi:10.15585/mmwr.mm6709e1
8. Peterson C, Xu L, Florence C, Mack KA. Opioid-related US 
hospital discharges by type, 1993-2016. J Subst Abuse Treat. 
Aug 2019;103:9-13. doi:10.1016/j.jsat.2019.05.003
9. Coffey W, Hunter A, Mobley E, Vivolo-Kantor A. Rural-
Urban Trends in Opioid Overdose Discharges in Missouri 
Emergency Departments, 2012-2016. J Rural Health. 
2019;36(2):177-186. doi:10.1111/jrh.12368
10. Faryar KA, Ems TI, Bhandari B, Huecker MR. Prevalence 
of Emergency Department Patients Presenting with 
Heroin or Prescription Opioid Abuse Residing in Urban, 
Suburban, and Rural Jefferson County. J Emerg Med. Nov 
2018;55(5):605-611. doi:10.1016/j.jemermed.2018.07.029
11. Greenwood-Ericksen MB, Kocher K. Trends in Emergency 
Department Use by Rural and Urban Populations in the 
United States. JAMA Network Open. 2019;2(4):e191919. 
doi:10.1001/jamanetworkopen.2019.1919
12. Casey MM, Wholey D, Moscovice IS. Rural Emergency 
Department Staffing and Participation in Emergency 
Certification and Training Programs. J Rural Health. 
2008;24(3):253-262. 
